Cisplatin-based combined modality therapy for anal carcinoma
- 20 February 2003
- Vol. 97 (5) , 1195-1202
- https://doi.org/10.1002/cncr.11161
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Squamous cell carcinoma of the anal canalInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaNew England Journal of Medicine, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.Journal of Clinical Oncology, 1996
- Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative SurgeryNew England Journal of Medicine, 1994
- Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoidInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatinRadiotherapy and Oncology, 1993
- Combined therapy for cancer of the anal canalDiseases of the Colon & Rectum, 1974